Shiseido (OTCMKTS: SSDOY) is one of 484 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare Shiseido to similar businesses based on the strength of its dividends, institutional ownership, profitability, analyst recommendations, earnings, risk and valuation.
Earnings & Valuation
This table compares Shiseido and its peers top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Shiseido||$8.97 billion||$202.92 million||43.42|
|Shiseido Competitors||$2.03 billion||$132.97 million||-3.56|
This table compares Shiseido and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk and Volatility
Shiseido has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Shiseido’s peers have a beta of 1.08, suggesting that their average share price is 8% more volatile than the S&P 500.
This is a summary of current ratings and target prices for Shiseido and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
As a group, “Pharmaceutical preparations” companies have a potential upside of 44.31%. Given Shiseido’s peers higher possible upside, analysts clearly believe Shiseido has less favorable growth aspects than its peers.
Shiseido pays an annual dividend of $0.21 per share and has a dividend yield of 0.3%. Shiseido pays out 14.6% of its earnings in the form of a dividend. As a group, “Pharmaceutical preparations” companies pay a dividend yield of 2.1% and pay out 31.8% of their earnings in the form of a dividend.
Insider and Institutional Ownership
0.1% of Shiseido shares are held by institutional investors. Comparatively, 47.0% of shares of all “Pharmaceutical preparations” companies are held by institutional investors. 15.3% of shares of all “Pharmaceutical preparations” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Shiseido beats its peers on 7 of the 12 factors compared.
Shiseido Company, Limited produces and sells cosmetics, cosmetics accessories, and toiletries in Japan and internationally. It also produces and sells health and beauty foods, and over-the-counter drugs; and beauty salon products. In addition, the company operates beauty salons, as well as restaurants. Further, it produces and sells cosmetic raw materials, medical-use drugs, medical cosmetics, purification/analytical equipment, and other products. The company sells its products through cosmetic specialty stores, department stores, general merchandise stores, drug stores, and perfumeries, as well as through mail-order. Shiseido Company, Limited was founded in 1872 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Shiseido Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shiseido and related companies with MarketBeat.com's FREE daily email newsletter.